Glucose Health Income After Taxes 2014-2019 | GLUC

Glucose Health income after taxes from 2014 to 2019. Income after taxes can be defined as earnings or losses after income tax expense but before minority interest, extraordinary items, discontinued operations, preferred dividends and accounting changes have been accounted for.

Glucose Health Income After Taxes 2014-2019 | GLUC

Glucose Health income after taxes from 2014 to 2019. Income after taxes can be defined as earnings or losses after income tax expense but before minority interest, extraordinary items, discontinued operations, preferred dividends and accounting changes have been accounted for.
Related Stocks
Company NameMarket
Cap
Abbott Laboratories (ABT)$206.3B
Stryker (SYK)$148B
Boston Scientific (BSX)$133.7B
EssilorLuxottica (ESLOY)$111.2B
Medtronic (MDT)$110.6B
Haleon (HLN)$44B
Lonza Group Ag (LZAGY)$42.2B
GE HealthCare Technologies (GEHC)$37.9B
ResMed (RMD)$36.6B
Terumo (TRUMY)$30.3B
Koninklijke Philips (PHG)$25.5B
Zimmer Biomet Holdings (ZBH)$22.3B
Insulet (PODD)$18.7B
Baxter (BAX)$17B
Smith & Nephew SNATS (SNN)$11.2B
BellRing Brands (BRBR)$9.9B
Bio-Rad Laboratories (BIO)$9.5B
Demant (WILYY)$8.3B
Lantheus Holdings (LNTH)$6.3B
TG Therapeutics (TGTX)$5.4B
Haemonetics (HAE)$4.4B
Prestige Consumer Healthcare (PBH)$4.2B
Perrigo (PRGO)$3.9B
ICU Medical (ICUI)$3.9B
Envista Holdings (NVST)$3.8B
Agios Pharmaceuticals (AGIO)$3.3B
Neogen (NEOG)$3.1B
Shandong Weigao Medical Polymer (SHWGF)$3B
GN Store Nord (GNNDY)$2.9B
QuidelOrtho (QDEL)$2.8B